Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

4 Nov 2011 07:00

RNS Number : 4856R
Biome Technologies PLC
04 November 2011
Ā 



4 November 2011

Biome Technologies plc

("the Group")

Trading Update

Biome Technologies plc today issues a trading update for the nine months ended 30 September 2011.

Highlights

·; Group revenue of £15.3m in the nine months to 30 September 2011 up 49% compared with the same period in 2010

·; Third quarter revenues of £4.3m within the Bioplastics Division 61% ahead of third quarter 2010

·; Closing cash position at 30 September 2011 was £3.0m

Ā·; Group trading performance remains in line with the Board's expectations for the year

Trading Update

Group revenues were £15.3m in the nine months to 30 September 2011 (Q3 2010: £10.3m). This reflected a 110% increase in bioplastic sales made by the UK based Biome Bioplastics, a 34% increase in sales in Stanelco RF Technologies division and a 29% increase in third party sales at the Biotec joint venture. The Group's cash position at 30 September 2011 was £3.0m (30 June 2011: £3.6m).

Bioplastics Division

Revenues in the Bioplastics Division increased from £8.5m to £12.9m in the nine months to 30 September 2011. This was comprised of revenues of £5.3m at Biome Bioplastics and £7.6m from 3rd party sales at the Biotec joint venture in the period.

In the third quarter, Biotec revenues were £2.7m (Q3 2010: £1.7m) benefiting from further abatement of capacity constraints in the supply chain and allowing some stock build within the business. Biome Bioplastics has achieved substantial growth in 2011 compared to comparative quarters in 2010. Q3 sales were £1.7m (Q3 2010 £0.9m). We continue to expect some quarterly volatility as the market reacts to easing of supply constraints.

Stanelco RF Technologies Division

The Stanelco RF Technologies Division continues to perform in line with management expectations with revenues increasing by 34% to £2.4m in the nine months to 30 September 2011. Phasing of sales of furnaces has been skewed to H1 in 2011 and Q3 revenues were £0.6m, below the £0.8m of Q3 2010. Progress continues to be made in broadening the business reach in the industrial marketplace.

Outlook

Trading performance remains in line with the Board's expectations for the year and we are well placed to continue delivering on our strategy through the remainder of 2011 and into 2012.

Ā 

-Ends-

Ā 

For further information please contact:

Ā 

Biome Technologies plc

Paul Mines, Chief Executive OfficerĀ 

Declan Brown, Group Finance Director

Tel: +44 (0) 2380 867 100

Ā 

Daniel Stewart & Company plc

Oliver Rigby (Nomad)

Martin Lampshire (Broker)

Ā 

Tel: +44 (0) 20 7776 6550

FTI Consulting

Oliver Winters

Latika Shah

Tel: +44 (0) 20 7831 3113

Ā 

Ā 

Ā 

Notes to Editor:

Ā 

Admitted to AIM in July 2010, the activities of Biome operate in two divisions; Biome Bioplastics and Stanelco RF Technologies. Both divisions are underpinned by the Group's skills in the commercialisation and development of innovative technology.

Ā 

The Group's core strategy is to develop and broaden its bioplastics business organically and is engaged with a variety of large-scale international customers and partners on a number of key commercial and development partnerships. These target applications in the food, horticulture and the electronics markets, amongst others, further enhance the Group's existing and new product development.

Ā 

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
TSTDKNDQOBDDPDK
Date   Source Headline
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSContract
17th Mar 20217:00 amRNSUpdate on biodegradable tree shelter project
16th Mar 20217:00 amRNSBiome commits to UN Race to Zero climate campaign
28th Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSUpdate on biodegradable tree shelter project
31st Dec 20201:30 pmRNSTotal Voting Rights
15th Dec 20207:00 amRNSBiome's RF division gains traction
11th Dec 20208:05 amRNSAdmission of Subscription Shares
6th Nov 20204:41 pmRNSSecond Price Monitoring Extn
6th Nov 20204:35 pmRNSPrice Monitoring Extension
4th Nov 20207:00 amRNSBiome starts biodegradable tree shelter project
30th Oct 20205:00 pmRNSTotal Voting Rights
30th Oct 20207:00 amRNSDirector/PDMR Shareholding
29th Oct 20207:01 amRNSAppointment of Group Chief Financial Officer
29th Oct 20207:00 amRNSTrading Update
22nd Oct 202012:28 pmRNSHolding(s) in Company
19th Oct 20202:17 pmRNSHolding(s) in Company
12th Oct 20204:07 pmRNSResult of General Meeting
1st Oct 202010:55 amRNSHolding(s) in Company
24th Sep 20207:05 amRNSProposed Fundraise of £1.1 million & Notice of GM
24th Sep 20207:00 amRNSInterim Results
26th Aug 20207:00 amRNSGrant funding from Innovate UK
19th Aug 20207:00 amRNSOrder for compostable bioplastic for coffee pods
30th Jul 20207:00 amRNSTrading Update
25th Jun 20203:46 pmRNSResult of Annual General Meeting
2nd Jun 202010:35 amRNSNotice of Annual General Meeting 2020
22nd Apr 20207:00 amRNSTrading Update
20th Apr 20202:16 pmRNSAnnual Report and Accounts
16th Apr 20207:00 amRNSFinal Results 2019
25th Mar 20207:00 amRNSUpdate re Final Results, 2019 Annual Report & AGM
13th Feb 20204:01 pmRNSNotification of awards under the 2017 LTIP
30th Jan 20204:10 pmRNSShare option awards in lieu of historic bonuses
30th Jan 20207:00 amRNSTrading statement and Board change
4th Nov 20197:00 amRNSBiome to present at Mello London 2019
31st Oct 20195:30 pmRNSTotal Voting Rights
31st Oct 20197:00 amRNSTrading update
30th Sep 20193:04 pmRNSResult of General Meeting
12th Sep 20197:05 amRNSProposed Placing to raise £1.3 million
12th Sep 20197:00 amRNSInterim Results
22nd Jul 20197:00 amRNSTrading Update
25th Jun 20199:17 amRNSLong Term Incentive Plan Second Vesting
17th Jun 20194:12 pmRNSDirector/PDMR/PCA Shareholding
14th Jun 20197:00 amRNSBioplastics Product Update
24th Apr 20191:59 pmRNSResult of Annual General Meeting
24th Apr 20197:00 amRNSTrading Update
4th Apr 201912:20 pmRNSDirector/PDMR/PCA Shareholding
29th Mar 20199:22 amRNSNotice of AGM and Annual Report
28th Mar 20197:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.